Lung Cancer, Small Cell: Clinical Trials

3 trials for Lung Cancer, Small Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Unknown 1

Follow Lung Cancer, Small Cell: new trials by email Literature Review of Lung Cancer, Small Cell trials Research Report on Lung Cancer, Small Cell

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
CT-0508, Pembrolizumab - HER2-positive, Adenocarcinoma
Phase 1UnknownCarisma Therapeutics Inc482021-02-022024-12-18
A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors
topotecan - Lung Cancer, Small Cell
Phase 1CompletedGlaxoSmithKline1072004-10-042017-11-14
A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors
topotecan - Lung Cancer, Small Cell, Solid Tumor Cancer
Phase 1CompletedGlaxoSmithKline12001-09-012017-05-30

Narrower conditions

Small Cell Lung Carcinoma (3)  ·  Adenocarcinoma (1)  ·  Bile Duct Neoplasms (1)  ·  Biliary Tract Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Ductal (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Carcinoma, Small Cell (1)  ·  Carcinoma, Squamous Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Colorectal Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Head and Neck Neoplasms (1)

Broader conditions

Bronchial Neoplasms (3)  ·  Carcinoma, Bronchogenic (3)  ·  Lung Diseases (3)  ·  Lung Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Neoplasms (3)  ·  Thoracic Neoplasms (3)  ·  Neoplasms (2)  ·  Adnexal Diseases (1)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Colonic Diseases (1)

Interventions

Topotecan (2)  ·  pembrolizumab (1)

Sponsors

GlaxoSmithKline (2)  ·  Carisma Therapeutics Inc (1)

Countries

United States (3)  ·  Canada (1)  ·  Netherlands (1)

Top investigators

Jeanett Wetzel (1)

Results publications

PMID 36441083, PMID 39726590, PMID 39920391